Research Comparison

HGH vs MK-677

Side-by-side research comparison of HGH and MK-677 across our PubMed, ClinicalTrials.gov, and EuropePMC corpus. 5 head-to-head studies plus 36 on HGH and 57 on MK-677.

5 head-to-head · 36 on HGH · 57 on MK-677

At a glance

  HGH MK-677
Drug class growth hormone n/a
Studies in corpus 36 57
Highest evidence tier rct rct
Evidence tier mix rct · 8 other · 8 case series · 1 review · 3 case report · 2 preclinical animal · 3 in vitro · 2 rct · 10 other · 10 review · 5 preclinical animal · 20 in vitro · 4 case report · 1
Studies with explicit sample size 6 8
Head-to-head studies in corpus 5

Lab evidence, head to head

Beyond the literature: here's what third-party Certificate-of-Analysis records (Janoshik, BCC, Auxlabs) say about real HGH and MK-677 batches we've tested. Aggregate, public data — cross-reference against the studies below.

HGH

We tested 415 HGH batches across 132 manufacturers, 96.71% avg purity.

415
Batches tested
132
Manufacturers
96.71%
Avg purity
2
Failed <90%
14
Underdosed >10%
All HGH COA records →

MK-677

We tested 68 MK-677 batches across 31 manufacturers, 98.6% avg purity.

68
Batches tested
31
Manufacturers
98.6%
Avg purity
5
Underdosed >10%
All MK-677 COA records →

We hold deeper lab coverage on HGH (415 batches tested). MK-677 edges ahead on average measured purity (96.71% vs 98.6%) — a narrow gap; weigh it against failed-batch and underdose counts above.

Head-to-head studies

Studies in our corpus that mention both HGH and MK-677 — the gold-standard direct comparison evidence.

Top studies per peptide

HGH (36 studies)

MK-677 (57 studies)

Vendor data

Looking for vendor-level purity, endotoxin, and HPLC data on HGH or MK-677? TitrateLab tracks Certificate-of-Analysis records from the major peptide labs (Janoshik, BCC, Auxlabs) alongside the research above. Cross-reference vendor batches against the studies on this page.

Explore each peptide